Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual Biologic and Small Molecule Therapy for the Treatment of Refractory Pediatric Inflammatory Bowel Disease
Inflamm. Bowel Dis. 2020 Oct 30;[EPub Ahead of Print], MT Dolinger, EA Spencer, J Lai, D Dunkin, MC DubinskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.